Key result
Surgical treatment of refractory amiodarone-induced thyrotoxicosis was successfully performed in a 19-year-old male with complex congenital heart disease using careful intraoperative TEE monitoring.
Why the study?
Amiodarone-induced thyrotoxicosis can be refractory to medical therapy, and its management in adult congenital heart disease post-Senning procedure had not been previously reported.
Population
19-year-old male with complex congenital heart disease post-Senning procedure and refractory amiodarone-induced thyrotoxicosis
Comparison
Surgical treatment with intraoperative transesophageal echocardiography monitoring
Design
Case report
Authors
Loading...
Supports surgical option in refractory amiodarone-induced thyrotoxicosis with complex congenital heart disease; leaves open need for prospective data.
Case Report (n=1)
No
Surgical treatment of medically refractory amiodarone-induced thyrotoxicosis is feasible in patients with complex congenital heart disease when supported by careful intraoperative monitoring such as transesophageal echocardiography.
El‐Asmar et al. (2020) conducted a case report in Amiodarone-induced thyrotoxicosis in complex congenital heart disease (n=1). Surgical treatment with intraoperative transesophageal echocardiography monitoring was evaluated on Successful operation. Surgical treatment of refractory amiodarone-induced thyrotoxicosis was successfully performed in a 19-year-old male with complex congenital heart disease using careful intraoperative TEE monitoring.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: